Couragene Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1M

  • Investors
  • 2

Couragene General Information

Description

Developer of a gene delivery platform designed to provide gene therapy. The company's technology provides oral drug delivery technology and gene medicine that leverages chemical engineering approaches to efficient intracellular delivery of genetic medicine payloads, such as proteins, gene editors, antibodies, mRNA, antisense oligos (ASOs), and DNA, enabling healthcare to overcome the delivery hurdles for the treatment of various diseases, including neurogenetic disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • New Jersey Bioscience Center
  • 675 US Highway 1
  • North Brunswick, NJ 08902
  • United States
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • New Jersey Bioscience Center
  • 675 US Highway 1
  • North Brunswick, NJ 08902
  • United States

Couragene Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Couragene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 20-May-2024 $1M Completed Generating Revenue
1. Seed Round 06-Sep-2022 Completed Generating Revenue
To view Couragene’s complete valuation and funding history, request access »

Couragene Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed III
Seed II
Seed I 4,000,000 $0.000000 $1 $1 1x $1 24.51%
To view Couragene’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Couragene Patents

Couragene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260191973-A1 Stimuli-responsive engineering platform for intracellular payload delivery Pending 09-Jan-2025
WO-2026151823-A2 Stimuli-responsive engineering platform for intracellular payload delivery Pending 09-Jan-2025
WO-2026151823-A3 Stimuli-responsive engineering platform for intracellular payload delivery Pending 09-Jan-2025
WO-2025245094-A2 Peptide sequences for improved delivery of proteins into nucleus Pending 21-May-2024 C12N9/226

Couragene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Couragene Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Foothill Ventures Venture Capital Minority
Hi2 Global Venture Capital Minority
To view Couragene’s complete investors history, request access »

Couragene Investments (1)

Couragene’s most recent deal was a Joint Venture with CourageAS Biotherapeutics. The deal was made on 14-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CourageAS Biotherapeutics 14-Feb-2025 Joint Venture Drug Discovery
To view Couragene’s complete investments history, request access »

Couragene FAQs

  • When was Couragene founded?

    Couragene was founded in 2022.

  • Where is Couragene headquartered?

    Couragene is headquartered in North Brunswick, NJ.

  • What is the size of Couragene?

    Couragene has 5 total employees.

  • What industry is Couragene in?

    Couragene’s primary industry is Drug Delivery.

  • Is Couragene a private or public company?

    Couragene is a Private company.

  • What is the current valuation of Couragene?

    The current valuation of Couragene is .

  • What is Couragene’s current revenue?

    The current revenue for Couragene is .

  • How much funding has Couragene raised over time?

    Couragene has raised $3.6M.

  • Who are Couragene’s investors?

    Foothill Ventures and Hi2 Global have invested in Couragene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process